a 802715 has been researched along with cyclosporine in 3 studies
Studies (a 802715) | Trials (a 802715) | Recent Studies (post-2010) (a 802715) | Studies (cyclosporine) | Trials (cyclosporine) | Recent Studies (post-2010) (cyclosporine) |
---|---|---|---|---|---|
9 | 0 | 0 | 30,547 | 3,802 | 6,558 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lin, Y; Mikhalsky, D; Schönharting, M; Segers, C; Waer, M | 1 |
Lin, Y; Mikhalsky, D; Schönharting, M; Segers, C; Tjandra-Maga, TB; Waer, M | 1 |
Ceuppens, J; Goebels, J; Kasran, A; Lin, Y; Rutgeerts, O; Schönharting, M; Van Gool, S; Waer, M | 1 |
3 other study(ies) available for a 802715 and cyclosporine
Article | Year |
---|---|
Xanthines: ideal immunosuppressants for combination with cyclosporine?
Topics: Animals; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Rats; Rats, Inbred Strains; Survival Rate; Transplantation, Homologous; Xanthines | 1996 |
Use of the methylxanthine derivative A802715 in transplantation immunology: II. In vivo experiments.
Topics: Administration, Oral; Animals; Cyclosporine; Drug Synergism; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Infusions, Intravenous; Lymphocyte Activation; Male; Pentoxifylline; Rats; Rats, Inbred Strains; Xanthines | 1997 |
Use of the methylxanthine derivative A802715 in transplantation immunology: I. Strong in vitro inhibitory effects on CD28-costimulated T cell activities.
Topics: Animals; Antibodies, Monoclonal; CD28 Antigens; CD3 Complex; Cyclosporine; Dose-Response Relationship, Drug; Drug Synergism; Humans; Immunosuppression Therapy; Interferon-gamma; Interleukin-10; Interleukin-6; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Mice; Pentoxifylline; Receptors, Interleukin-2; T-Lymphocytes; Transplantation Immunology; Tumor Necrosis Factor-alpha; Xanthines | 1997 |